What is the real cost of bevacizumab for patients with advanced bowel cancer?

摘要

During this time of intense scrutiny of health-care budgets, compelling evidence of significant benefit to any treatment is essential. However, exactly what constitutes 'significant benefit' is open to debate. Increasingly, as a society we need resources to be used effectively, and unfortunately this does not always align with providing the best possible treatment for every individual.